MedicaidPrior AuthMedium impact
Asparlas™ (calaspargase pegol-mknl) (Revised)
Humana·LA · Oncology, Hematology, Pediatrics·Medicaid
We identified it
Jul 21, 2026
Summary
Unable to provide complete analysis. This policy is a revised Prior Authorization requirement for Asparlas™ (calaspargase pegol-mknl) for Louisiana Medicaid members, but only a summary source is available without specific policy content. The billing team cannot implement changes without access to the full policy document detailing authorization criteria, affected patient populations, required documentation, and effective dates.
Action Required
URGENT: Billing team must immediately access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a584852 to determine: (1) Effective date of this revised policy, (2) Specific prior authorization requirements for Asparlas™ (J9118), (3) Required clinical criteria and supporting documentation, (4) Any changes from the previous version. Update billing software and provider communication materials once full policy details are available. Do not delay—this 1-day-old policy may already be in effect.